Valley Care And Rehab Llc Medicare and Medicaid Location: 600 Fifth Street Southeast, Box 129, Barnesville, Minnesota 56514 Ratings: Phone: (218) 354-2254 |
News Archive
NeurogesX, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved Qutenza(TM) (capsaicin) 8% patch, the first and only product containing prescription strength capsaicin, for the management of neuropathic pain due to postherpetic neuralgia (PHN), the nerve pain which can follow shingles.
BioSan Laboratories announced today a recall of products in its Essentials™ and RightFoods™ lines because they may contain undeclared soy. BioSan Laboratories has not received any reports of adverse or allergic reactions to these products. Although the levels of soy are low, people with soy allergies risk an allergic reaction if they consume these products.
Genzyme Corporation announced today that it will reopen enrollment in the Alglucosidase Alfa Temporary Access Program (ATAP), a program which provides access to treatment for severely affected adults with Pompe disease prior to commercial approval of Lumizyme™ (alglucosidase alfa). Genzyme and the FDA have also agreed on a path toward approval of Lumizyme.
United Benefit Advisors, LLC (UBA), one of the nation's leading employee benefits advisory organizations, today announced the opening of the 2011 UBA Benefit Opinions Survey, which delineates employers' opinions in five key areas: Health Plan Strategies, Benefits Philosophy and Opinion, Health Plan Management, Personal Health Management and Employee Communications.
› Verified 8 days ago